Andriy Rusyn
Impact in
- Neurology top 5%
- Barrier Structure and Function Studies
- Gastroenterology top 10%
- Gastrointestinal Tumor Research and Treatment
Papers in
- Oncology 11
- HER2/EGFR in Cancer Research 4
- Neutropenia and Cancer Infections 3
-
- Gastric Cancer Management and Outcomes 5
- Co-authors
- I. Bazin (7 shared papers)Uğur Şahin (7 shared papers)Bohuslav Melichar (7 shared papers)Florian Lordick (7 shared papers)Ihor Vynnychenko (7 shared papers)Martin Schüler (7 shared papers)Assen Dudov (7 shared papers)Igor Bondarenko (6 shared papers)
In The Last Decade
Andriy Rusyn
16 papers receiving 506 citations
Andriy Rusyn's Hit Papers
Peers
Comparison fields: 5 of 45
- Neurology 126
- Gastroenterology 51
- Oncology 234
- Pulmonary and Respiratory Medicine 168
- Immunology 88
Countries citing papers authored by Andriy Rusyn
This map shows the geographic impact of Andriy Rusyn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andriy Rusyn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andriy Rusyn more than expected).
Fields of papers citing papers by Andriy Rusyn
This network shows the impact of papers produced by Andriy Rusyn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andriy Rusyn. The network helps show where Andriy Rusyn may publish in the future.
Co-authors
The 25 scholars most cited alongside Andriy Rusyn, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | FAST: a randomised phase II study of zolbetuximab (IMAB362) plus EOX versus EOX alone for first-line treatment of advanced CLDN18.2-positive gastric and gastro-oesophageal adenocarcinoma Hit paper breakdown → | 2021 | 265 |
| 2 | 2017 | 96 | |
| 3 | 2016 | 35 | |
| 4 | 2019 | 25 | |
| 5 | 2019 | 18 | |
| 6 | 2016 | 18 | |
| 7 | 2019 | 16 | |
| 8 | 2017 | 9 | |
| 9 | 2016 | 9 | |
| 10 | 2017 | 7 | |
| 11 | 2017 | 5 | |
| 12 | 2016 | 4 | |
| 13 | 2016 | 2 | |
| 14 | 2023 | 1 | |
| 15 | DENTAL STATUS FEATURES IN PATIENTS DURING ANTI-CANCER CHEMOTHERAPY (TRANSCARPATHIAN ANTITUMOR CENTER EXPERIENCE). | 2020 | 1 |
| 16 | 2017 | 1 |
About Andriy Rusyn
Andriy Rusyn is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Neurology, Radiology, Nuclear Medicine and Imaging and Genetics, having authored 16 papers that have together received 512 indexed citations. Recurring topics across this work include Barrier Structure and Function Studies (5 papers), Gastric Cancer Management and Outcomes (5 papers), HER2/EGFR in Cancer Research (4 papers), Neutropenia and Cancer Infections (3 papers), Blood disorders and treatments (3 papers), Biosimilars and Bioanalytical Methods (2 papers), Antibiotics Pharmacokinetics and Efficacy (2 papers) and Radiopharmaceutical Chemistry and Applications (2 papers). The work is most often cited by research in Neurology (126 citations), Gastroenterology (51 citations), Oncology (234 citations), Pulmonary and Respiratory Medicine (168 citations) and Immunology (88 citations). Andriy Rusyn has collaborated with scholars based in Ukraine, Russia and Bulgaria. Frequent co-authors include I. Bazin, Uğur Şahin, Bohuslav Melichar, Florian Lordick, Ihor Vynnychenko, Martin Schüler, Assen Dudov, Igor Bondarenko, Christoph Huber and Daniel Maurus. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, European Journal of Cancer, Cancer Chemotherapy and Pharmacology and The Lancet Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.